Results 171 to 180 of about 750,611 (331)
The Effect of Expected Effective Corporate Tax Rates on Incremental Financing Decisions
, 1997 Reint Gropp
openalex +2 more sources
Diversity and Determinants of Corporate Financing Decisions: Survey Evidence [PDF]
, 2004 Alan Goodacre +2 more
openalex +1 more source
The Determinants of Capital Structure: Some Evidence from Banks [PDF]
This paper documents that standard cross-sectional determinants of firm leverage also apply to the capital structure of large banks in the United States and Europe. We find a remarkable consistency in sign, significance and economic magnitude.
Gropp, Reint Eberhard, Heider, Florian
core
Advanced Functional Materials, EarlyView.The study presents biodegradable and recyclable mixed‐matrix membranes (MMMs), hydrogels, and cryogels using luminescent nanoscale metal‐organic frameworks (nMOFs) and biopolymers. These bio‐nMOF‐MMMs combine europium‐based nMOFs as probes for the status of the materials with the biopolymers agar and gelatine and present alternatives to conventional ...
Moritz Maxeiner +4 more
wiley +1 more source
Corporate Finance in Europe Confronting Theory with Practice [PDF]
, 2004 Dirk Brounen +2 more
openalex +1 more source
Bank Supervision and Corporate Finance [PDF]
We examine the impact of bank supervision on the financing obstacles faced by almost 5,000 corporations across 49 countries. We find that firms in countries with strong official supervisory agencies that directly monitor banks tend to face greater ...
Asli Demirguc-Kunt +2 more
core
Advanced Functional Materials, EarlyView.The study presents an injectable hydrogel with tunable microporosity to improve mesenchymal stem cell delivery for volumetric muscle loss treatment. Mesenchymal stem cells encapsulated in porous hydrogels significantly promote the spreading, proliferation, and cytokine secretion of mesenchymal stem cells.
Hana Yasue +3 more
wiley +1 more source
The Stock Market and the Financing of Corporate Growth in Africa: The Case of Ghana [PDF]
, 2006 Charles Amo Yartey
openalex +2 more sources
Advanced Functional Materials, EarlyView.Zr‐Fe MOF@Ribociclib@Herceptin (ZFRH) efficiently targets/kills Human Epidermal Growth Factor Receptor 2/Estrogen Receptor‐positive (HER2/ER+) breast cancer cells. It combats tumors by: 1) Elevating ROS, altering redox balance; 2) Inhibiting transcription; 3) Inducing pyroptosis.
Hongkun Miao +8 more
wiley +1 more source